Leukemia
Showing NaN - NaN of 79
Chronic Myeloproliferative Disorders, GVHD, Leukemia Trial in Buffalo (sargramostim)
Completed
- Chronic Myeloproliferative Disorders
- +5 more
- sargramostim
-
Buffalo, New YorkRoswell Park Cancer Institute
Oct 3, 2022
Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in United States (CYNK-001)
Recruiting
- Leukemia
- +19 more
- CYNK-001
-
Denver, Colorado
- +9 more
Sep 9, 2022
Blood and Bone Marrow Samples in Chronic Myelogenous Leukemia
Active, not recruiting
- Leukemia
- DNA analysis
- +3 more
-
San Diego, California
- +160 more
Aug 2, 2022
Bone Marrow and Blood Samples in Untreated Acute Myeloid
Completed
- Leukemia
- laboratory biomarker analysis
-
San Diego, California
- +45 more
Aug 2, 2022
Tissue and Blood Samples From Acute Myeloid Leukemia
Active, not recruiting
- Leukemia
- DNA analysis
- +7 more
-
Mountain View, California
- +76 more
Aug 2, 2022
Hematopoietic and Lymphoid System Tumor, Leukemia, Lymphoma Trial in Canada, United States (procedure, biological, other)
Active, not recruiting
- Hematopoietic and Lymphoid System Neoplasm
- +3 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +3 more
-
Birmingham, Alabama
- +42 more
Jul 20, 2022
Verification in Pediatric Chronic GvHD: ABLE 2.0 / PTCTC GVH
Recruiting
- Chronic Graft-versus-Host-Disease
- +4 more
-
San Francisco, California
- +15 more
Jun 17, 2022
Leukemia Trial in Canada, United States (cytarabine, daunorubicin, midostaurin)
Leukemia, Lymphoma Trial in United States (biological, drug, procedure)
Active, not recruiting
- Leukemia
- Lymphoma
- rituximab
- +7 more
-
Duarte, California
- +24 more
Aug 16, 2021
Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia
Active, not recruiting
- Leukemia
- +2 more
- laboratory biomarker analysis
-
San Diego, California
- +50 more
Aug 16, 2021
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Buffalo (biological, drug, radiation)
Completed
- Chronic Myeloproliferative Disorders
- +7 more
- anti-thymocyte globulin
- +8 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Jul 19, 2021
Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in Buffalo (donor lymphocytes)
Completed
- Leukemia
- +3 more
- donor lymphocytes
-
Buffalo, New YorkRoswell Park Cancer Institute
Aug 21, 2020
Leukemia Trial in Canada, United States (biological, drug, other, procedure)
Completed
- Leukemia
- anti-thymocyte globulin
- +10 more
-
Birmingham, Alabama
- +51 more
Apr 7, 2020
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Buffalo (biological, drug, procedure)
Completed
- Chronic Myeloproliferative Disorders
- +7 more
- anti-thymocyte globulin
- +11 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Jan 29, 2020
GVHD, Leukemia, Lymphoma Trial in Buffalo (biological, drug, procedure, radiation)
Completed
- Graft Versus Host Disease
- +4 more
- anti-thymocyte globulin
- +8 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Nov 25, 2019
Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in United States (biological, drug, procedure, radiation)
Withdrawn
- Leukemia
- +4 more
- alemtuzumab
- +6 more
-
La Jolla, California
- +23 more
Nov 25, 2019
Leukemia, Myeloproliferative Disorders, Myelodysplastic-Myeloproliferative Diseases Trial in Canada, United States (Allogeneic
Completed
- Leukemia
- +2 more
- Allogeneic bone marrow transplantation
- Peripheral blood stem cell transplantation
-
Birmingham, Alabama
- +44 more
Oct 24, 2017
Leukemia Trial in Buffalo (rituximab, lenalidomide)
Completed
- Leukemia
- rituximab
- lenalidomide
-
Buffalo, New YorkRoswell Park Cancer Institute
Jun 9, 2017
Bladder Cancer, Cervical Cancer, Esophageal Cancer Trial in Buffalo (bupropion HCl, )
Completed
- Bladder Cancer
- +10 more
- bupropion hydrochloride
- placebo
-
Buffalo, New YorkRoswell Park Cancer Institute
Apr 24, 2017
Bladder Cancer, Cervical Cancer, Esophageal Cancer Trial in Buffalo (behavioral, drug, other)
Completed
- Bladder Cancer
- +10 more
- telephone-based intervention
- +4 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Dec 14, 2016